970 resultados para AN-1
Resumo:
Intervenientischer Burgerschafft
Resumo:
Titelbl. gestempelt: Privatbibl. Karl Rohm sen.; hs Notiz auf Titelbl.: seltener Privatdruck aus der Privatbibl. eines militanten Antisemiten
Resumo:
Boberach: Der Rechenschaftsbericht bietet einen Abriß der Geschichte der Preußischen Nationalversammlung und bekennt sich zur Republik, für die das deutsche Volk aber noch nicht reif ist. Die oktroyierte Verfassung wird strikt abgelehnt. - Wentzke: Für die Republik ist Deutschland noch nicht reif. Die Einzelstaaten müssen mit den Rechten der Selbständigkeit bestehen bleiben, geben aber von ihrer Souveränität an den Gesamtstaat soviel ab, daß die Einheit, Sicherheit nach Innen, Macht nach Außen, gegründet werden kann. - Für Preußen demokratisch-konstitutionelle Monarchie. Gegen die oktroyierte Verfassung
Resumo:
Boberach: Ein jüdischer Einwohner Frankfurts, dem nach einem Aufenthalt von 21 Jahren zunächst das Frankfurter Bürgerrecht in Aussicht gestellt worden war, beschwert sich darüber, daß er wegen seines Auftretens in Volksversammlungen verhaftet und ausgewiesen wurde und verlangt ein Gerichtsverfahren oder Genugtuung, nachdem er sich um Schutz durch seine württembergische Heimatbehörde bemüht hat
Resumo:
Welsch (Projektbearbeiter): Appell von 20 Berliner Urwählern, nur Wahlmänner zu wählen, die die oktroyierte Verfassung vom 5. Dezember 1848 anerkennen
Resumo:
Interleukin-1β (IL-1β) is a key cytokine involved in inflammatory illnesses including rare hereditary diseases and common chronic inflammatory conditions as gout, rheumatoid arthritis, and type 2 diabetes mellitus, suggesting reduction of IL-1β activity as new treatment strategy. The objective of our study was to assess safety, antibody response, and preliminary efficacy of a novel vaccine against IL-1β. The vaccine hIL1bQb consisting of full-length, recombinant IL-1β coupled to virus-like particles was tested in a preclinical and clinical, randomized, placebo-controlled, double-blind study in patients with type 2 diabetes. The preclinical simian study showed prompt induction of IL-1β-specific antibodies upon vaccination, while neutralizing antibodies appeared with delay. In the clinical study with 48 type 2 diabetic patients, neutralizing IL-1β-specific antibody responses were detectable after six injections with doses of 900 µg. The development of neutralizing antibodies was associated with higher number of study drug injections, lower baseline body mass index, improvement of glycemia, and C-reactive protein (CRP). The vaccine hIL1bQb was safe and well-tolerated with no differences regarding adverse events between patients receiving hIL1bQb compared to placebo. This is the first description of a vaccine against IL-1β and represents a new treatment option for IL-1β-dependent diseases such as type 2 diabetes mellitus (ClinicalTrials.gov NCT00924105).Molecular Therapy (2016); doi:10.1038/mt.2015.227.
Resumo:
Welsch (Projektbearbeiter): Rechenschaftslegung über die Spendeneinnahmen des Vereins sowie deren Verwendung (Auszahlung von Löhnen für öffentliche Erdarbeiten)
Resumo:
Welsch (Projektbearbeiter): Aufforderung an die Nationalgardisten des ersten Wiener Bezirks zur Besetzung der Posten im Schottenhof
Resumo:
Welsch (Projektbearbeiter): Anordnung, die Erdgeschosse der Häuser in der Innenstadt nächtens zu beleuchten
Resumo:
It is still controversial which mediators regulate energy provision to activated neural cells, as insulin does in peripheral tissues. Interleukin-1β (IL-1β) may mediate this effect as it can affect glucoregulation, it is overexpressed in the 'healthy' brain during increased neuronal activity, and it supports high-energy demanding processes such as long-term potentiation, memory and learning. Furthermore, the absence of sustained neuroendocrine and behavioral counterregulation suggests that brain glucose-sensing neurons do not perceive IL-1β-induced hypoglycemia. Here, we show that IL-1β adjusts glucoregulation by inducing its own production in the brain, and that IL-1β-induced hypoglycemia is myeloid differentiation primary response 88 protein (MyD88)-dependent and only partially counteracted by Kir6.2-mediated sensing signaling. Furthermore, we found that, opposite to insulin, IL-1β stimulates brain metabolism. This effect is absent in MyD88-deficient mice, which have neurobehavioral alterations associated to disorders in glucose homeostasis, as during several psychiatric diseases. IL-1β effects on brain metabolism are most likely maintained by IL-1β auto-induction and may reflect a compensatory increase in fuel supply to neural cells. We explore this possibility by directly blocking IL-1 receptors in neural cells. The results showed that, in an activity-dependent and paracrine/autocrine manner, endogenous IL-1 produced by neurons and astrocytes facilitates glucose uptake by these cells. This effect is exacerbated following glutamatergic stimulation and can be passively transferred between cell types. We conclude that the capacity of IL-1β to provide fuel to neural cells underlies its physiological effects on glucoregulation, synaptic plasticity, learning and memory. However, deregulation of IL-1β production could contribute to the alterations in brain glucose metabolism that are detected in several neurologic and psychiatric diseases.Molecular Psychiatry advance online publication, 8 December 2015; doi:10.1038/mp.2015.174.